Form 4: CBRE CFO Giamartino Reports Equity Award, Stock Sales
Insider Transaction Report
CBRE Group's CFO, Emma E. Giamartino, reported the acquisition of an annual equity award and subsequent sales of Class A Common Stock.
Summary
- Emma E. Giamartino, CFO & Chief Investment Officer of CBRE Group, Inc., reported transactions involving Class A Common Stock.
- On February 25, 2026, Giamartino acquired 10,900 shares of Class A Common Stock as part of her 2026 annual equity award, with a grant price of $0.0000.
- These acquired shares will vest at a rate of 25% per year on February 25, 2027, 2028, 2029, and 2030.
- Also on February 25, 2026, Giamartino disposed of 943 shares at a price of $147.24 per share, likely for tax withholding purposes related to the equity award.
- On February 26, 2026, Giamartino sold 9,223 shares of Class A Common Stock at a price of $148.61 per share.
- All transactions were made pursuant to a Rule 10b5-1(c) plan.
- Following these transactions, Giamartino beneficially owns 126,501 shares of Class A Common Stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral. The equity award grant is a positive for executive compensation, while the subsequent sales, though pre-planned, are a routine part of insider financial management and do not inherently signal a strong positive or negative outlook for the company.
Positives
- The reporting person, Emma E. Giamartino, received an annual equity award of 10,900 shares, indicating continued compensation and alignment with shareholder interests.
Negatives
- The sale of 9,223 shares by a key executive, even if pre-planned, could be perceived by some investors as a slight negative signal regarding future stock performance.
Future Outlook
The acquired equity award shares will vest over a four-year period, with 25% vesting annually on February 25th from 2027 through 2030, subject to specific award agreement conditions.
Industry Context
StockSavvy.ai notes that Form 4 filings are routine disclosures of insider trading activity. The grant of equity awards is a common component of executive compensation packages, and subsequent sales, especially those executed under a Rule 10b5-1 plan, are often for personal financial planning, tax obligations, or diversification rather than a direct signal about the company's immediate prospects.
Comparison to Industry Standards
- This Form 4 filing reports standard insider transactions, including an equity award grant and subsequent sales, which are common practices across publicly traded companies for executive compensation and personal financial management.
- The use of a Rule 10b5-1 plan for the sales aligns with best practices for insiders to avoid accusations of trading on material non-public information, a standard observed by executives in companies like JLL or Cushman & Wakefield within the broader real estate services industry.
Stakeholder Impact
- Shareholders are informed of executive stock ownership changes, which can influence market perception and confidence in management's alignment with shareholder interests.
Next Steps
- The remaining 75% of the 2026 annual equity award shares will vest in 25% increments on February 25, 2028, 2029, and 2030.
Key Dates
| Date | Description |
|---|---|
| 02/25/2026 | Date of acquisition of 10,900 Class A Common Stock shares as part of the 2026 annual equity award and disposition of 943 shares for tax withholding. |
| 02/26/2026 | Date of sale of 9,223 Class A Common Stock shares. |
| 02/27/2026 | Date the Form 4 was signed. |
| 02/25/2027 | First vesting date for 25% of the 2026 annual equity award. |
| 02/25/2028 | Second vesting date for 25% of the 2026 annual equity award. |
| 02/25/2029 | Third vesting date for 25% of the 2026 annual equity award. |
| 02/25/2030 | Fourth and final vesting date for 25% of the 2026 annual equity award. |
Keywords
CBRE, Form 4, Insider Transaction, Equity Award, Stock Sale, CFO, Giamartino, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.